-
Therapeutic Efficacy
Randomized controlled trials using imaging to assess the effect of novel therapies, including in high-risk oncology and HIV populations
-
Comparative Effectiveness and Resource Utilization
Randomized controlled trials to determine the effectiveness of cardiovascular imaging on health outcomes and processes of care
-
Artificial Intelligence in Cardiothoracic Imaging
We are running our first clinical trial with machine learning using imaging for risk prediction and to guide clinical decision-making
-
Mechanisms of Cardiovascular Disease
Multi-modal, multi-tissue imaging to derive unique insights into pathobiological mechanisms contributing to cardiovascular disease
-
REPRIEVE Trial
A randomized controlled trial to prevent vascular events in patients with HIV using pitavastatin
-
Atrium Trial
Abatacept for immune checkpoint inhibitor associated myocarditis; a randomized, double-blind, placebo-controlled trial
-
Epidemiology of Cardiovascular Disease
Including baseline exposures, genetic determinants, cardiometabolic imaging phenotyping and outcomes
